These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37675016)

  • 1. Endotoxin removal therapy with Polymyxin B immobilized fiber column as a COVID-19-bedside strategy protocol for endotoxic shock.
    De Rosa S; Zanella M; Samoni S; Ronco C
    Front Nephrol; 2022; 2():847305. PubMed ID: 37675016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
    Shoji H; Opal SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry.
    De Rosa S; Cutuli SL; Ferrer R; Antonelli M; Ronco C;
    Artif Organs; 2021 Jun; 45(6):E187-E194. PubMed ID: 33377184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis.
    De Rosa S; Villa G; Ronco C
    Artif Organs; 2020 Feb; 44(2):184-186. PubMed ID: 31386769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry.
    Forin E; Lorenzoni G; Ferrer R; De Cal M; Zanella M; Marchionna N; Gregori D; Forfori F; Lorenzin A; Danzi V; Ronco C; De Rosa S
    Sci Rep; 2023 Oct; 13(1):17600. PubMed ID: 37845296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential survival benefit and early recovery from organ dysfunction with polymyxin B hemoperfusion: perspectives from a real-world big data analysis and the supporting mechanisms of action.
    Shoji H; Ferrer R
    J Anesth Analg Crit Care; 2022 Jun; 2(1):27. PubMed ID: 37386673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.
    Mitaka C; Kusaoi M; Kawagoe I; Satoh D
    Acute Crit Care; 2021 May; 36(2):85-91. PubMed ID: 33813808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry.
    Cutuli SL; Artigas A; Fumagalli R; Monti G; Ranieri VM; Ronco C; Antonelli M;
    Ann Intensive Care; 2016 Dec; 6(1):77. PubMed ID: 27502196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
    Lee WY; Kim HJ; Kim EY
    Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.
    Terada-Hirashima J; Izumi S; Katagiri D; Uemura Y; Mikami A; Sugiura W; Abe S; Azuma A; Sugiyama H
    JMIR Res Protoc; 2022 Nov; 11(11):e37426. PubMed ID: 36126219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
    Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
    J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.